MedTrace Logo

The Effect of Methylphenidate on Primary Enuresis in Children With Attention Deficit Hyperactivity Disorder

NCT02699528 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2016-09-16

No results posted yet for this study

Summary

To assess wether methylphenidate reduces the prevalence of primary nocturnal enuresis in children with attention deficit disorder

Conditions

  • Attention Deficit Hyperactivity Disorder
  • Enuresis

Interventions

DRUG

methylphenidate

The drug will be prescribed as indicated for attention deficit disorder

Sponsors & Collaborators

  • Meir Medical Center

    lead OTHER

Principal Investigators

  • Nathan Watemberg, MD · Meir Medical Center

Eligibility

Min Age
5 Years
Max Age
10 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-05-31
Primary Completion
2017-04-30
Completion
2017-05-31

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02699528 on ClinicalTrials.gov